[HTML][HTML] Haptoglobin administration into the subarachnoid space prevents hemoglobin-induced cerebral vasospasm

M Hugelshofer, RM Buzzi, CA Schaer… - The Journal of …, 2019 - Am Soc Clin Investig
Delayed ischemic neurological deficit (DIND) is a major driver of adverse outcomes in
patients with aneurysmal subarachnoid hemorrhage (aSAH), defining an unmet need for …

[引用][C] Haptoglobin administration into the subarachnoid space prevents hemoglobin-induced cerebral vasospasm

M Hugelshofer, RM Buzzi… - The Journal of …, 2019 - research-collection.ethz.ch
Haptoglobin administration into the subarachnoid space prevents hemoglobin-induced cerebral
vasospasm - Research Collection Header Upper Right Menu Log in de jump to …

Haptoglobin administration into the subarachnoid space prevents hemoglobin-induced cerebral vasospasm

M Hugelshofer, RM Buzzi… - The Journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Delayed ischemic neurological deficit (DIND) is a major driver of adverse outcomes in
patients with aneurysmal subarachnoid hemorrhage (aSAH), defining an unmet need for …

Haptoglobin administration into the subarachnoid space prevents hemoglobin-induced cerebral vasospasm.

M Hugelshofer, RM Buzzi, CA Schaer… - Journal of Clinical …, 2019 - go.gale.com
Aneurysmal subarachnoid hemorrhage (aSAH) represents 5%-10% of all strokes and has
an estimated global incidence of 6.67 per 100,000 people (1, 2). The loss of productive life …

Haptoglobin administration into the subarachnoid space prevents hemoglobin-induced cerebral vasospasm.

M Hugelshofer, RM Buzzi, CA Schaer… - The Journal of …, 2019 - europepmc.org
Delayed ischemic neurological deficit (DIND) is a major driver of adverse outcomes in
patients with aneurysmal subarachnoid hemorrhage (aSAH), defining an unmet need for …

Haptoglobin administration into the subarachnoid space prevents hemoglobin-induced cerebral vasospasm

M Hugelshofer, RM Buzzi, CA Schaer… - Journal of Clinical …, 2019 - zora.uzh.ch
Delayed ischemic neurological deficit (DIND) is a major driver of adverse outcomes in
patients with aneurysmal subarachnoid hemorrhage (aSAH) defining an unmet need for …

Haptoglobin administration into the subarachnoid space prevents hemoglobin-induced cerebral vasospasm.

M Hugelshofer, RM Buzzi, CA Schaer, H Richter… - The Journal of clinical …, 2019 - sonar.ch
English Delayed ischemic neurological deficit (DIND) is a major driver of adverse outcomes
in patients with aneurysmal subarachnoid hemorrhage (aSAH), defining an unmet need for …

Haptoglobin administration into the subarachnoid space prevents hemoglobin-induced cerebral vasospasm.

M Hugelshofer, RM Buzzi, CA Schaer… - The Journal of clinical …, 2019 - folia.unifr.ch
English Delayed ischemic neurological deficit (DIND) is a major driver of adverse outcomes
in patients with aneurysmal subarachnoid hemorrhage (aSAH), defining an unmet need for …

[HTML][HTML] Haptoglobin administration into the subarachnoid space prevents hemoglobin-induced cerebral vasospasm

M Hugelshofer, RM Buzzi, CA Schaer… - The Journal of …, 2019 - ncbi.nlm.nih.gov
Delayed ischemic neurological deficit (DIND) is a major driver of adverse outcomes in
patients with aneurysmal subarachnoid hemorrhage (aSAH), defining an unmet need for …

Haptoglobin administration into the subarachnoid space prevents hemoglobin-induced cerebral vasospasm.

M Hugelshofer, RM Buzzi, CA Schaer… - The Journal of …, 2019 - europepmc.org
Delayed ischemic neurological deficit (DIND) is a major driver of adverse outcomes in
patients with aneurysmal subarachnoid hemorrhage (aSAH), defining an unmet need for …